Inactive Instrument
4 Sc AG Stock Deutsche Boerse AG
Stocks
DE0005753818
Biotechnology & Medical Research
|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 17/10/25 | 4SC AG, Q3 2025 Earnings Call, Oct 17, 2025 | |
| 08/08/25 | 4SC AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
Last Transcript: 4 Sc AG
| 17/10/25 | 4SC : Quarterly Report Q3 2025 Conference Call | PU |
| 17/10/25 | 4SC : Q3 Announcement 2025 | PU |
| 17/04/25 | 4SC : Q1 Announcement 2025 | PU |
| 17/10/24 | 4SC : publishes Q3 2024 report | PU |
| 17/10/24 | 4SC : Q3 Announcement 2024 | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | - | 14/11/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Manfred Rüdiger
BRD | Director/Board Member | 61 | 16/08/2005 |
| Chairman | 67 | 19/09/2014 | |
Helmut Jeggle
BRD | Director/Board Member | 55 | 05/06/2008 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.73% | +7.82% | +73.81% | +102.34% | 70.1B | |
| -0.26% | +0.69% | +37.80% | +66.05% | 54.93B | |
| -0.22% | +33.59% | +8.43% | +489.75% | 28.89B | |
| +0.04% | +10.49% | +48.44% | +7.45% | 23.9B | |
| -0.06% | +0.61% | -16.45% | -13.26% | 23.3B | |
| -1.37% | +7.87% | +251.71% | +464.53% | 18.41B | |
| -0.47% | +7.88% | +40.87% | -20.12% | 18.77B | |
| -0.57% | +3.44% | +25.60% | +619.86% | 16.1B | |
| -1.85% | -11.15% | +32.75% | +134.11% | 12.48B | |
| Average | -0.61% | +8.38% | +55.89% | +205.63% | 29.65B | |
| Weighted average by Cap. | -0.52% | +9.43% | +54.30% | +167.29% |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
